Stem cell-based test predicts leukemia patients' response to therapy to help tailor treatment
Wednesday, December 7, 2016 - 15:31
in Health & Medicine
Leukemia researchers have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.